Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,975 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The utility of urinary myo-inositol as a marker of glucose intolerance.
Ikezaki H, Furusyo N, Okada K, Ihara T, Hayashi T, Ogawa E, Kainuma M, Murata M, Hayashi J. Ikezaki H, et al. Among authors: hayashi j, hayashi t. Diabetes Res Clin Pract. 2014 Jan;103(1):88-96. doi: 10.1016/j.diabres.2013.11.018. Epub 2013 Dec 4. Diabetes Res Clin Pract. 2014. PMID: 24377833
Glycated albumin as a diagnostic tool for diabetes in a general Japanese population.
Ikezaki H, Furusyo N, Ihara T, Hayashi T, Ura K, Hiramine S, Mitsumoto F, Takayama K, Murata M, Kohzuma T, Ai M, Schaefer EJ, Hayashi J. Ikezaki H, et al. Among authors: hayashi j, hayashi t. Metabolism. 2015 Jun;64(6):698-705. doi: 10.1016/j.metabol.2015.03.003. Epub 2015 Mar 14. Metabolism. 2015. PMID: 25817605
The relation of postprandial plasma glucose and serum endostatin to the urinary albumin excretion of residents with prediabetes: results from the Kyushu and Okinawa Population Study (KOPS).
Shimizu M, Furusyo N, Tanaka Y, Kato Y, Mitsumoto-Kaseida F, Takayama K, Ura K, Hiramine S, Hayashi T, Ikezaki H, Ihara T, Mukae H, Ogawa E, Toyoda K, Kainuma M, Murata M, Hayashi J. Shimizu M, et al. Among authors: hayashi j, hayashi t. Int Urol Nephrol. 2016 Jun;48(6):851-7. doi: 10.1007/s11255-016-1258-3. Epub 2016 Mar 16. Int Urol Nephrol. 2016. PMID: 26984739
Ribavirin concentration in the later stages of 48 week pegylated interferon-alpha2b plus ribavirin therapy for chronic hepatitis C is useful for predicting virological response.
Furusyo N, Murata M, Ogawa E, Toyoda K, Ihara T, Ikezaki H, Hayashi T, Koga T, Kainuma M, Hayashi J. Furusyo N, et al. Among authors: hayashi j, hayashi t. J Antimicrob Chemother. 2011 May;66(5):1127-39. doi: 10.1093/jac/dkr034. Epub 2011 Feb 22. J Antimicrob Chemother. 2011. PMID: 21393126
Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1.
Ogawa E, Furusyo N, Murata M, Ikezaki H, Ihara T, Hayashi T, Toyoda K, Taniai H, Okada K, Kainuma M, Hayashi J. Ogawa E, et al. Among authors: hayashi j, hayashi t. J Hepatol. 2012 Sep;57(3):534-40. doi: 10.1016/j.jhep.2012.04.027. Epub 2012 May 18. J Hepatol. 2012. PMID: 22613000
9,975 results